Stay updated on Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial page.

Latest updates to the Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page now indicates recruitment is closed ('No longer looking for participants'), which directly affects potential participant access. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the page with an Intervention/Treatment header and a revision tag (v3.6.0).SummaryDifference0.4%

- Check14 days agoChange DetectedThe page’s revision label was updated from v3.5.4 to v3.5.5, indicating a small maintenance update to the page metadata rather than a change to study content or results.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a software update or patch applied to the ClinicalTrials.gov page rendering; it does not change the study details, locations, or eligibility criteria.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page footer revision has been updated from v3.5.2 to v3.5.3, reflecting a minor website version change without altering the displayed trial information.SummaryDifference0.1%

- Check64 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check85 days agoChange DetectedStandardized the disease name hyphenation to 'Alpha-1 antitrypsin deficiency'.SummaryDifference0.1%

Stay in the know with updates to Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial page.